Cite
TYPE-1 CANNABINOID RECEPTOR EFFECT ON HUMAN COLONIC MOTILITY IN PATIENTS WITH SLOW TRANSIT CONSTIPATION AND CONTROLS
MLA
Altomare, A., et al. Type-1 Cannabinoid Receptor Effect on Human Colonic Motility in Patients with Slow Transit Constipation and Controls. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3983..4f3df36250ab80a3c313dcbd4e366d67&authtype=sso&custid=ns315887.
APA
Altomare, A., Guarino, M., Bisogno, T., Cocca, S., Alloni, R., Maccarrone, M., & Cicala, M. (2018). Type-1 Cannabinoid Receptor Effect on Human Colonic Motility in Patients with Slow Transit Constipation and Controls.
Chicago
Altomare, A, Mpl Guarino, T Bisogno, S Cocca, R Alloni, M Maccarrone, and M Cicala. 2018. “Type-1 Cannabinoid Receptor Effect on Human Colonic Motility in Patients with Slow Transit Constipation and Controls,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3983..4f3df36250ab80a3c313dcbd4e366d67&authtype=sso&custid=ns315887.